Chicago Capital Management, LLC — 13F Holdings & Portfolio
CIK 1580162 · latest 13F-HR filed 2026-07-22
Chicago Capital Management, LLC manages $112.3M in 13F-reported U.S. long-equity assets across 27 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are NUVL (9.84%), APGE (8.73%), GTLS (7.44%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 14 new positions, exited 16, added to 5, and trimmed 0.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
SUITE 6025
CHICAGO, IL 60606
$112.3M
Long-equity book
27
Distinct positions
2026-06-30
Filed 2026-07-22
+14 / −16 / ↑5 / ↓0
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- VERITONE INC$3.0M +121.8%
- RAPID7 INC$2.0M +47.2%
- HEWLETT PACKARD ENTERPRISE C$1.7M +78.5%
- SABRE GLBL INC$1.1M +17.8%
- XEROX HOLDINGS CORP$279.2K +24.0%
New Positions
- NUVALENT INC$11.1M
- APOGEE THERAPEUTICS INC$9.8M
- TAYLOR MORRISON HOME CORP$7.2M
- AMPHASTAR PHARMACEUTICALS IN$5.0M
- FIVE9 INC$4.5M
Exited Positions
- JANUS HENDERSON GROUP PLC$8.2M
- ARCELLX INC$8.0M
- AMICUS THERAPEUTIC$7.2M
- IRONWOOD PHARMACEUTICALS INC$6.9M
- CRACKER BARREL OLD CTRY STOR$6.8M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | NUVALENT INC | NUVL | 670703107 | $11.1M | 9.84% | 115,500 | SH |
| 2 | APOGEE THERAPEUTICS INC | APGE | 03770N101 | $9.8M | 8.73% | 97,100 | SH |
| 3 | CHART INDS INC | GTLS | 16115Q308 | $8.4M | 7.44% | 53,000 | SH |
| 4 | BANDWIDTH INC | BAND | 05988JAD5 | $7.6M | 6.79% | 8,153 | PRN |
| 5 | TAYLOR MORRISON HOME CORP | TMHC | 87724P106 | $7.2M | 6.39% | 133,000 | SH |
| 6 | SABRE GLBL INC | SABR | 78573NAK8 | $7.1M | 6.34% | 6,904 | PRN |
| 7 | RAPID7 INC | RPD | 753422AF1 | $6.3M | 5.62% | 6,520 | PRN |
| 8 | MGP INGREDIENTS INC NEW | MGPI | 55303JAB2 | $5.9M | 5.28% | 6,068 | PRN |
| 9 | VERITONE INC | VERI | 92347MAB6 | $5.4M | 4.80% | 5,500 | PRN |
| 10 | AMPHASTAR PHARMACEUTICALS IN | AMPH | 03209RAB9 | $5.0M | 4.43% | 5,440 | PRN |
| 11 | THE REALREAL INC | REAL | 88339PAD3 | $4.8M | 4.26% | 5,307 | PRN |
| 12 | FIVE9 INC | FIVN | 338307AF8 | $4.5M | 3.99% | 5,000 | PRN |
| 13 | SHAKE SHACK INC | SHAK | 819047AB7 | $4.0M | 3.53% | 4,189 | PRN |
| 14 | ETSY INC | ETSY | 29786AAN6 | $3.9M | 3.50% | 4,292 | PRN |
| 15 | HEWLETT PACKARD ENTERPRISE C | HPEPC | 42824C208 | $3.8M | 3.39% | 32,900 | SH |
| 16 | SAREPTA THERAPEUTICS INC | SRPT | 803607AD2 | $3.0M | 2.67% | 3,170 | PRN |
| 17 | CATALYST PHARMACEUTICALS INC | CPRX | 14888U101 | $2.9M | 2.61% | 122,650 | SH |
| 18 | ASTRONOVA INC | ALOT | 04638F108 | $2.8M | 2.54% | 131,100 | SH |
| 19 | ESPERION THERAPEUTICS INC NE | ESPR | 29664W105 | $2.6M | 2.32% | 830,935 | SH |
| 20 | BIO-TECHNE CORP | TECH | 09073M104 | $2.0M | 1.80% | 37,509 | SH |
| 21 | XEROX HOLDINGS CORP | XRXDW | 98421MAE6 | $1.4M | 1.29% | 4,000 | PRN |
| 22 | PAR TECHNOLOGY CORP | PAR | 698884AE3 | $1.1M | 0.96% | 1,127 | PRN |
| 23 | TRUBRIDGE INC | TBRG | 205306103 | $685.8K | 0.61% | 34,663 | SH |
| 24 | STELLAR BANCORP INC | STEL | 858927106 | $342.4K | 0.30% | 11,559 | SH |
| 25 | ELECTRONIC ARTS INC | EA | 285512109 | $309.2K | 0.28% | 2,000 | SH |
| 26 | NSTS BANCORP INC | NSTS | 6293JP109 | $303.8K | 0.27% | 29,020 | SH |
| 27 | XEROX HOLDINGS CORP | XRXDW | 98421M114 | $26.4K | 0.02% | 95,980 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-07-22 | $112.3M | 27 | 0001062993-26-003767 |
| 2026-03-31 | 2026-04-27 | $120.7M | 29 | 0001062993-26-002171 |
| 2025-12-31 | 2026-02-02 | $146.9M | 43 | 0001062993-26-000528 |